Evaluation of a Potential Metabolism-Mediated Drug-Drug ... - NCBI

Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers. Todor I(1), Popa A, Neag M, ...

 

Comparative efficacy and acceptability of atomoxetine ... - NCBI

Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder ...

 

Atomoxetine and Wellbutrin XL Drug Interactions - Drugs.com

BuPROPion may increase the blood levels and effects of atomoxetine. This can increase side effects such as dizziness, dry mouth, loss of appetite, sleep ...

 

Bupropion for adults with attention‐deficit hyperactivity disorder ...

19 Dec 2011 ... Results: A total of 349 participants (n for bupropion treatment = 175) in five ... However, only atomoxetine is approved for this condition. Similar ...

 

(PDF) Evaluation of a Potential Metabolism-Mediated Drug-Drug ...

PDF | Purpose: To evaluate the impact of bupropion on the pharmacokinetic profile of atomoxetine and its main active metabolite (glucuronidated form), ...

 

A Network Meta-Analysis of Atomoxetine, Methylphenidate ...

A Network Meta-Analysis of Atomoxetine, Methylphenidate, Lisdexamfetamine, and Bupropion for the Treatment of Attention Deficit Hyperactivity Disorder in ...

 

Strattera vs. Wellbutrin Treatment for ADHD In Children: Difference ...

6 Feb 2019 ... Strattera (atomoxetine) and Wellbutrin (bupropion) are different types of antidepressants used to treat attention deficit hyperactivity disorder ...

 

A retrospective claims analysis of combination therapy in the ...

8 Jun 2009 ... Dispensing events were grouped into 6 categories: atomoxetine (ATX), ... (SAS), bupropion (BUP), and Alpha-2 Adrenergic Agonists (A2A).

 

ADHD - The BMJ

8 Aug 2018 ... lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil. When assessing both efficacy and safety it ...

 

Update on Treating ADHD - ASCP Annual Meeting (Formerly NCDEU)

31 May 2018 ... Pharmacologic Treatments for ADHD. Primary Agents. Stimulants. Atomoxetine. ∝ adrenergic agonists. Secondary Agents. Bupropion.